United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-014_b8792837-f86a-4e67-b1a5-ec8ca278fe77
- Product NDC
- 13668-014
- Form
- TABLET
- Composition / generic term
- Levetiracetam
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090115
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (13668-014-05) · 13668-014-05
- 120 TABLET in 1 BOTTLE (13668-014-12) · 13668-014-12
- 250 TABLET in 1 BOTTLE (13668-014-25) · 13668-014-25
- 2500 TABLET in 1 BOTTLE (13668-014-31) · 13668-014-31
- 60 TABLET in 1 BOTTLE (13668-014-60) · 13668-014-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →